Michael Forster

Interim Chair and Regents Professor Pharmacology & Neuroscience ; Member Institute for Healthy Aging

University of North Texas Health Science Center

Affiliations

College of Biomedical and Translational Sciences

Pharmacology and Neuroscience

College of Nursing

Undergraduate Studies

University of North Texas Health Science Center

College of Public Health

Focused on Resources for her Health Education and Research (FOR HER)

Texas Center for Health Disparities

School Of Public Health

Department Of Behavioraland Community Health

Graduate School of Biomedical Sciences ; Pharmacology & Neuroscience ; Institute for Healthy Aging

School of Biomedical Sciences

Pharmacology and Neuroscience

Texas College of Osteopathic Medicine

Michael Forster is currently serving as a College Of Biomedical And Translational Sciences Interim Chair and Regents Professor Pharmacology & Neuroscience ; Member Institute for Healthy Aging at University of North Texas Health Science Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael Forster

University of North Texas Health Science Center

Interim Chair and Regents Professor Pharmacology & Neuroscience ; Member Institute for Healthy Aging

You can click a keyword to filter the displayed items

neuroscience pharmacology neuropsychopharmacology neuropharmacology physiology ageing pharmacological research behavioral neuroscience neuroscience of aging behavioural pharmacology experimental gerontology aging cell psychopharmacology metabolism biochemistry addiction biology psychoactive drugs molecular neurodegeneration oxidative stress addiction free radical biology molecular pharmacology cognitive impairment aging-associated diseases biogerontology experimental pharmacology dopamine cannabis use addictive behaviors cell metabolism redox biology brain health pharmacotherapy aging process lifespan extension pharmacological studies antioxidants addiction medicine caloric restriction novel synthetic cannabinoids memory studies nutritional neuroscience mitochondrial function nutritional biochemistry energy homeostasis alcohol dependence brain function behavioural physiology memory loss physical aging neurochemistry synthetic cathinones molecular nutrition brain-immune interaction aldehyde dehydrogenase neuroprotection substance addiction discriminative stimulus effects reactive oxygen species mitochondrial biogenesis brain science degenerative pathology procedural memory caloric intake oxidative damage behavioral effects energy metabolism cognitive function aged mice different strains different tissues different brain regions protein oxidation coenzyme q10 life span coenzyme q life expectancy psychomotor performance skeletal muscle alzheimer disease autoimmunity pharmaceutical preparations hydrogen peroxide mass spectrometry mitochondrial proteins gaba-a receptors sulfhydryl compounds dihydrolipoamide dehydrogenase glutathione disulfide energy intake cognition nicotine memory disorders nutrition

Notable Scholarly Works

Notable Federal Grants

Collaborators

Behavioral Pharmacology of Novel Synthetic Indazole, Indole, and Benzimidazole Cannabinoids in Rodents. Journal of Cannabis Research (2026)

benzimidazole cannabinoidsneuropharmacologypharmacological studiesapplied pharmacologynovel synthetic indazoleneuropsychopharmacologycannabis usebehavioural pharmacologybehavioral pharmacologypharmacologypsychopharmacologydrug discoverypharmacological researchpsychoactive drugs

Discriminative Stimulus and Locomotor Activity Profiles of Nicotine and Varenicline. Pharmacology Biochemistry and Behavior (2026)

neuropharmacologynicotineneuropsychopharmacologybehavioural pharmacologypsychopharmacologybehavioral sciences

Locomotor and Discriminative Stimulus Effects of N-Cyclohexyl Butylone and N-Cyclohexyl Methylone. Frontiers in Pharmacology (2026)

neuropharmacologyphysiologyapplied pharmacologypharmacological studiesneuropsychopharmacologybehavioral neuroscienceneurosciencemovement disordersexperimental pharmacologyneurophysiologybehavioural pharmacologypharmacologypsychopharmacologypharmacological research

Behavioral Effects of Three Synthetic Tryptamine Derivatives in Rodents. Journal of Psychopharmacology (2025)

neuropharmacologybehavioral experimentsneuropsychopharmacologybehavioral neurosciencedopaminebehavioural pharmacologypharmacologypsychopharmacologysynthetic tryptamine derivativespharmacological research

Locomotor Stimulant and Drug Discrimination Effects of Five Synthetic Cathinones in Rodents. Pharmacology Biochemistry and Behavior (2025)

synthetic cathinonesneuropharmacologypharmacological studiesneuropsychopharmacologybehavioral neuroscienceneuroscienceexperimental pharmacologybehavioural pharmacologypharmacologypsychopharmacologylocomotor stimulantdrug discrimination effectspharmacological researchpsychoactive drugs

PHENETHYLAMINYLATION: Preliminary in Vitro Evidence for the Covalent Transamidation of Psychedelic Phenethylamines to Glial Proteins Using 3,5-Dimethoxy-4-(2-Propynyloxy)-Phenethylamine as a Model Compound. bioRxiv (Cold Spring Harbor Laboratory) (2025)

neurochemistrypharmaceutical chemistryneuropharmacologycheminformaticscovalent transamidationneuropsychopharmacologybiochemistryexperimental pharmacologychemical biologyvitro evidencepsychedelic phenethylaminespharmacologymolecular pharmacologyneurotransmitterspharmacological researchmolecular psychiatry

Protective Effects of Sa-31 in a Psychostimulant-Induced Neurotoxicity Model Using Sh-Sy5Y Cells. European Journal of Pharmaceutical Sciences (2025)

toxicologyneurochemistrypsychostimulant-induced neurotoxicity modelneuroprotectionneuropharmacologymolecular pharmacologyaddiction biologyneuropsychopharmacologyneurosciencesh-sy5y cellsexperimental pharmacologypharmacologypsychopharmacologymolecular neuroscienceprotective effectspharmacological research

Lifelong Glutathione Deficiency in Mice Increased Lifespan and Delayed Age-Related Motor Declines. Aging and Disease (2024)

neuroscience of agingaging cellmolecular neurodegenerationphysiologybiogerontologyageingneurodegenerative diseaseslifelong glutathione deficiencykinesiologyexperimental gerontologyoxidative stressphysical aginglifespan extensionlongevityaging process

Locomotor and Discriminative Stimulus Effects of Nboh Hallucinogens in Rodents. Behavioural Pharmacology (2024)

neuropharmacologyphysiologyanimal cognitionneuropsychopharmacologybehavioral neuroscienceneuroscienceneurobiological mechanismsnboh hallucinogensneurophysiologybehavioural pharmacologyanimal behaviornervous systemneurotransmitterscentral nervous systembehavioural physiology

Optimizing the Training Conditions of Rats in Nicotine Drug Discrimination Studies. Drug and Alcohol Dependence (2024)

substance use disorderstraining conditionsneuropharmacologynicotinetobacco usebehavioral experimentsaddiction biologyneuropsychopharmacologybehavioral neuroscienceaddictionbehavioural pharmacologypharmacologypsychopharmacologypharmacological researchpsychoactive drugsbehavioral sciencesaddictive behaviors